Middle East and Africa Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class ; Route of Administration ; Application ; and Distribution Channel, and Country
Market Introduction Gastrointestinal drugs include promotility drugs, antimotility drugs, and drugs for acid-related disorders.The generally used gastrointestinal drugs as a group are considered safe.
Gastrointestinal (GI) disease affects the stomach, pancreas, rectum and large intestine, esophagus, small intestine, gallbladder, and liver. The main symptoms of gastrointestinal disorders are indigestion, heartburn, constipation bloating, and so on.
Market Overview and Dynamics The Middle East & Africa gastrointestinal drugs market is expected to reach US$ 2,573.94 million by 2027 from US$ 2,000.27 million in 2019. The market is anticipated to grow at a CAGR of 3.3% during 2019–2027. The rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the major factors expected to boost the growth of the gastrointestinal drugs market in Middle East & Africa. However, the market is likely to get impacted by the risk factor such as low awareness associated with gastrointestinal disorders in low-income economies during the forecast period.
Key Market Segments In terms of drug class, the acid neutralizers segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.In terms of route of administration, oral segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.
In terms of application, the inflammatory ulcerative colitis segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019. In terms of distribution channel, the retail pharmacies segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.
Major Sources and Companies Listed Several major primary and secondary sources associated with the Middle East & Africa gastrointestinal drugs market report are the World Health Organization (WHO), Celiac Disease Foundation, International Foundation for Gastrointestinal Disorders, and others.
MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SEGMENTATION
By Drug Class • Acid Neutralizers • Antidiarrheal and Laxatives • Anti-Inflammatory Drugs • Antiemetic and Antinauseants • Biologics • Others
27 pages •
By Euromonitor International
• Nov 2020
COVID-19 has forced consumers to spend more time at home in 2020, with consumers unable or unwilling to eat or drink at foodservice outlets as often. Furthermore, with many consumers working from home more eating habits have also been affected with consumers eating less fast food and unhealthy snacks. All of these factors have helped to reduce...
The global over the counter drugs market is expected to grow with a CAGR of 6.65% during the forecasted period. The growth propelling factors of this market are product innovations, high penetration in the emerging market, favourable regulatory framework, and inclination of pharmaceutical companies toward OTC drugs from Rx drugs.
Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.